Published 10 June 2009, doi:10.1136/bmj.b1210
Cite this as: BMJ 2009;338:b1210

Endgames

Picture quiz

A 2 year old girl with fever, cough, and tachypnoea

Marc Tebruegge, honorary clinical research fellow1, Nicole Ritz, honorary clinical research fellow1, Tom Connell, consultant in paediatric infectious diseases1, Nigel Curtis, professor and head of paediatric infectious diseases2

1 Infectious Diseases Unit, Department of General Medicine & Murdoch Children’s Research Institute, Royal Children’s Hospital Melbourne, Victoria 3052, Australia, 2 Department of Paediatrics, University of Melbourne, Royal Children’s Hospital Melbourne, Victoria 3052, Australia

N Curtis nigel.curtis{at}rch.org.au

A 2 year old girl presented to the accident and emergency department with high grade fever (temperature 39.2oC), cough, tachypnoea (respiratory rate 45 breaths/min), and lethargy. She had been unwell for six weeks with general malaise and intermittent fever. She had also been anorexic for three weeks and had lost about 7% of her body weight. She was born in Australia to parents from the South Pacific Islands. Her routine immunisations were up to date and her past medical history was unremarkable.

The patient underwent chest radiography (fig 1Go).


Figure 1
View larger version (174K):
[in this window]
[in a new window]
[PowerPoint Slide for Teaching]
 
Fig 1 Chest radiograph of a 2 year old girl with high grade fever, cough, and tachypnoea

 

Questions

1 What two major abnormalities can be seen on her chest radiograph?
2 What is the most likely diagnosis?
3 Which three additional investigations are most useful to confirm the diagnosis?

Answers

Short answers

1 The two major abnormalities that can be seen on the patient’s chest radiograph are a cavitating pulmonary lesion and widespread bilateral fine reticulogranular (miliary) shadowing (fig 2Go).


Figure 2
View larger version (173K):
[in this window]
[in a new window]
[PowerPoint Slide for Teaching]
 
Fig 2 Chest radiograph showing bilateral miliary infiltrates and outlining the cavitating pulmonary lesion in the left lower lobe (arrows)

 
2 On the basis of the history and the radiographic findings the most likely diagnosis is miliary tuberculosis.
3 A tuberculin skin test (Mantoux test), microscopy and culture of appropriate clinical specimens (such as sputum, gastric aspirates, bronchoalveolar lavage fluid, urine, cerebrospinal fluid, and blood), and an interferon-{gamma} release assay are the most useful initial tests.

Long answers
1 Abnormalities on radiography
The finding of bilateral fine reticulogranular (miliary) shadowing on chest radiography is considered a cardinal diagnostic feature in miliary tuberculosis.1 Between 50% and 90% of affected patients show a "classic" miliary pattern, consisting of small discrete opacities with widespread distribution throughout the lung fields.2 3 4 The differential diagnosis for this classic appearance includes Pneumocystis jiroveci pneumonia, lymphocytic interstitial pneumonitis, and viral pneumonia. A non-miliary pattern—with asymmetrical nodules, coalescence of nodules, or a mottled appearance—is less common. Other features, such as hilar lymphadenopathy, pleural effusion, segmental consolidation, and (as in our case) pulmonary cavitation may also be present.2 3 5 A small proportion of patients with miliary tuberculosis develop parenchymal air leaks, which can result in pneumothorax, pneumopericardium, or pneumomediastinum.5 6 7 8 9

Other imaging modalities can reveal further foci of disseminated infection. In our patient, who was also irritable and lethargic at presentation, a cranial magnetic resonance imaging scan showed multiple inflammatory foci scattered throughout the brain, corresponding to cerebral miliary lesions (fig 3Go).


Figure 3
View larger version (38K):
[in this window]
[in a new window]
[PowerPoint Slide for Teaching]
 
Fig 3 Axial (A) and coronal (B) sections of a cranial magnetic resonance imaging scan showing multiple enhancing lesions (arrows) scattered throughout the brain parenchyma, which correspond to miliary foci

 
2 Miliary tuberculosis
Worldwide, tuberculosis is responsible for approximately two million deaths a year.10 Historically, it has been thought that children contribute little to the overall burden of tuberculosis, but of the eight million new cases of tuberculosis reported globally in 2000 an estimated 11% occurred in children.11

Miliary tuberculosis is the result of haematogenous spread of Mycobacterium tuberculosis from a pulmonary or extrapulmonary focus, and it accounts for 1-5% of all cases of tuberculosis.2 Although predominately a disease of infants and young children, the reported incidence of miliary tuberculosis in adults in the United Kingdom has increased over the past few decades.12 Predisposing factors include pregnancy, malnutrition, diabetes mellitus, chronic renal failure, treatment with immunosuppressive drugs (such as high dose corticosteroids) or immunomodulatory drugs (such as infliximab or etanercept), malignancies, and HIV infection.2 3 13

The presenting features of miliary tuberculosis include fever, night sweats, malaise, anorexia, weight loss, cough, peripheral lymphadenopathy, and hepatosplenomegaly.1 2 14 The last two features are more commonly found in children.2 In addition, although rare, fundoscopic examination may reveal pathognomonic choroidal tubercles.

3 Other investigations
The diagnosis of active tuberculosis in children is most commonly based on the triad of an abnormal chest radiograph, a positive tuberculin skin test, and a history of contact with an infectious tuberculosis index case.15

The tuberculin skin test involves injecting purified protein derivative intradermally. The test result is read after 48-72 hours by measuring the diameter of induration around the injection site. Importantly, interpretation of this test may be confounded by several factors, including previous BCG immunisation, previous exposure to environmental mycobacteria, immunosuppression, and immunodeficiency.16 17 In common with other severe forms of tuberculosis, a large proportion of patients with miliary tuberculosis exhibit tuberculin anergy, resulting in false negative test results.2 18 In one study, only 26% of children with miliary tuberculosis had a positive tuberculin skin test at presentation.1 Therefore, although a negative result does not exclude active tuberculosis in this setting, a positive result in conjunction with typical radiographical findings supports the presumptive diagnosis.

Isolation of M tuberculosis confirms the diagnosis of tuberculosis and can provide important drug susceptibility data. However, tuberculosis is less often microbiologically confirmed in children than in adults. The decision to start antituberculous treatment usually needs to be made before confirmation of diagnosis by cultures, which may take several weeks to yield a positive result. Despite this, microscopy and culture of appropriate clinical specimens (such as sputum, gastric aspirates, bronchoalveolar lavage fluid, blood, and urine) should be done in all cases of suspected miliary tuberculosis.2 19 Notably, mycobacterial blood cultures are positive in only about a third of children with miliary tuberculosis.4

The latest guidelines from the National Institute for Health and Clinical Excellence also recommend performing a lumbar puncture in all patients with suspected miliary tuberculosis, on the basis of the fact that 10-30% of patients with this condition have evidence of tuberculous meningitis.2 20 Other invasive tests, such as bone marrow and liver biopsy, have relatively low yields.21

Interferon-{gamma} release assays, which have only relatively recently become commercially available, offer another means of supporting the diagnosis of tuberculosis. Two assays are currently licensed for use in the UK—QuantiFERON-TB Gold and T-Spot.TB. Both entail the detection of interferon-{gamma} released from T cells after stimulation of the patient’s blood with M tuberculosis specific antigens in vitro. Data on the use of these assays for the diagnosis of tuberculosis specifically in children are scarce,22 and some studies suggest that these assays perform less well in children than in adults.23 24 Limited evidence suggests, however, that the sensitivity of these assays for active tuberculosis in children is similar to or greater than that of the tuberculin skin test.25 Despite this fact, in a recent position statement released in 2008, the Health Protection Agency highlights that interferon-{gamma} release assays "should currently not be used as a routine diagnostic tool for active tuberculosis."26 Nevertheless, as with a positive tuberculin skin test in this setting, a positive interferon-{gamma} release assay result supports the presumptive diagnosis, although a negative test should not be used to exclude tuberculosis.

In conclusion, none of the currently available diagnostic tests for tuberculosis is sufficiently sensitive to reliably rule out active tuberculosis. Given that miliary tuberculosis is almost always fatal without specific treatment, clinicians should have a low threshold to start antituberculous treatment if the history, symptoms and radiographic findings suggest this diagnosis.2

Cite this as: BMJ 2009;338:b1210


Acknowledgments: We thank Dr Renata Kukuruzovic for her kind assistance.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent obtained.

References

  1. Gurkan F, Bosnak M, Dikici B, Bosnak V, Yaramis A, Tas MA, et al. Miliary tuberculosis in children: a clinical review. Scand J Infect Dis 1998;30:359-62.[CrossRef][Web of Science][Medline]
  2. Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 2005;5:415-30.[CrossRef][Web of Science][Medline]
  3. Kwong JS, Carignan S, Kang EY, Muller NL, FitzGerald JM. Miliary tuberculosis. Diagnostic accuracy of chest radiography. Chest 1996;110:339-42.[CrossRef][Web of Science][Medline]
  4. Hussey G, Chisholm T, Kibel M. Miliary tuberculosis in children: a review of 94 cases. Pediatr Infect Dis J 1991;10:832-6.[Web of Science][Medline]
  5. Aktogu S, Yorgancioglu A, Cirak K, Kose T, Dereli SM. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5480 cases. Eur Respir J 1996;9:2031-5.[Abstract]
  6. Wammanda RD, Ameh EA, Ali FU. Bilateral pneumothorax complicating miliary tuberculosis in children: case report and review of the literature. Ann Trop Paediatr 2003;23:149-52.[CrossRef][Web of Science][Medline]
  7. Mert A, Bilir M, Akman C, Ozaras R, Tabak F, Ozturk R, et al. Spontaneous pneumothorax: a rare complication of miliary tuberculosis. Ann Thorac Cardiovasc Surg 2001;7:45-8.[Medline]
  8. Das M, Chandra U, Natchu M, Lodha R, Kabra SK. Pneumomediastinum and subcutaneous emphysema in acute miliary tuberculosis. Indian J Pediatr 2004;71:553-4.[Medline]
  9. Krishnaswami KV. Mediastinal emphysema in miliary tuberculosis. J Indian Med Assoc 1977;69:227-9.[Medline]
  10. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21.[Abstract/Free Full Text]
  11. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004;8:636-47.[Web of Science][Medline]
  12. Jacques J, Sloan JM. The changing pattern of miliary tuberculosis. Thorax 1970;25:237-40.[Abstract/Free Full Text]
  13. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003;3:148-55.[CrossRef][Web of Science][Medline]
  14. Sharma SK, Mohan A, Pande JN, Prasad KL, Gupta AK, Khilnani GC. Clinical profile, laboratory characteristics and outcome in miliary tuberculosis. QJM 1995;88:29-37.[Abstract/Free Full Text]
  15. Starke JR. Diagnosis of tuberculosis in children. Pediatr Infect Dis J 2000;19:1095-6.[Web of Science][Medline]
  16. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204.[Web of Science][Medline]
  17. Marais BJ, Graham SM, Cotton MF, Beyers N. Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis 2007;196(suppl 1):S76-85.[CrossRef][Web of Science][Medline]
  18. Schuit KE. Miliary tuberculosis in children. Clinical and laboratory manifestation in 19 patients. Am J Dis Child 1979;133:583-5.[Abstract/Free Full Text]
  19. Willcox PA, Potgieter PD, Bateman ED, Benatar SR. Rapid diagnosis of sputum negative miliary tuberculosis using the flexible fibreoptic bronchoscope. Thorax 1986;41:681-4.[Abstract/Free Full Text]
  20. National Institute for Health and Clinical Excellence. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2006. www.nice.org.uk/guidance/index.jsp?action=byID&r=true&o=10980
  21. Irfan M, Hussain SF, Jabeen K, Islam M. Drug susceptibility pattern of Mycobacterium tuberculosis in adult patients with miliary tuberculosis. Trop Doct 2007;37:182-4.[Abstract/Free Full Text]
  22. Lalvani A, Millington KA. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis 2007;20:264-71.[Web of Science][Medline]
  23. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS One 2008;3:e2624.[CrossRef][Medline]
  24. Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006;61:616-20.[Abstract/Free Full Text]
  25. Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007;45:322-8.[CrossRef][Web of Science][Medline]
  26. Health Protection Agency. Position statement on the use of interferon gamma release assay (IGRA) tests for tuberculosis (TB). 2008. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1214808549127

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?



Access jobs at BMJ Careers
Whats new online at Student 

BMJ